Exhibit 107
Calculation of Filing Fee Tables
424(b)(5)
(Form Type)
Krystal Biotech, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type |
Security Title |
Fee Calculation or Carry Forward Rule |
Amount Registered |
Proposed Unit |
Maximum Price |
Fee Rate |
Amount of Registration Fee |
Carry Form |
Carry Forward File Number |
Carry Forward Initial Effective Date |
Filing Fee Previously Paid in Connection with Unsold Securities to Be Carried Forward | |||||||||||||
| Newly Registered Securities | ||||||||||||||||||||||||
| Fees to Be Paid |
Equity | Common Stock, par value $0.00001 per share | 457(o) | — | — | $150,000,000 | 0.0001102 | $16,530 | ||||||||||||||||
| Carry Forward Securities | ||||||||||||||||||||||||
| Carry Forward Securities |
— | — | — | — | — | — | — | — | ||||||||||||||||
| Total Offering Amounts | $150,000,000 | $16,530.00 | ||||||||||||||||||||||
| Total Fees Previously Paid | — | |||||||||||||||||||||||
| Total Fee Offsets | $11,182.75 | |||||||||||||||||||||||
| Net Fee Due | $5,347.25 | |||||||||||||||||||||||
Table 2: Fee Offset Claims and Sources
| Registrant or Filer Name |
Form or Filing Type |
File Number |
Initial Filing Date |
Filing Date |
Fee Offset Claimed |
Security Type Associated with Fee Offset Claimed |
Security Title Associated with Fee Offset Claimed |
Unsold Securities Associated with Fee Offset Claimed |
Unsold Aggregate Amount with Fee Offset Claimed |
Fee Paid with Fee Offset Source | ||||||||||||
| Rule 457(p) | ||||||||||||||||||||||
| Fee Offset Claim | Krystal Biotech, Inc. | 424(b)(5) | 333-237983 | December 31, 2020 | $11,182.75(2) | Equity | Common Stock, $0.00001 par value per share (3) | — | $102,500,000 | |||||||||||||
| Fee Offset Sources | Krystal Biotech, Inc. | 424(b)(5) | 333-237983 | December 31, 2020 | $11,182.75(2) | |||||||||||||||||
| (1) | In accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended (the “Securities Act”), the registrant initially deferred payment of all of the registration fees for the Registration Statement on Form S-3 (Registration No. 333-271167), filed on April 6, 2023. |
| (2) | On December 31, 2020, the registrant filed a prospectus supplement (the “2020 Prospectus Supplement”) to the prospectus included in its Registration Statement on Form S-3 (Registration Statement No. 333-237983) (the “2020 Registration Statement”) and concurrently submitted a fee of $16,365. The 2020 Prospectus Supplement related to the registrant’s offer and sale from time to time of shares of the registrant’s common stock, par value $0.00001 per share, having an aggregate gross sales price of up to $150,000,000 from time to time under an at-the-market program. As of the date of this prospectus supplement, $102,500,000 remains unsold under the at-the-market program. The 2020 Registration Statement and the offering that included the unsold securities under the 2020 Prospectus Supplement have been terminated. Pursuant to Rule 457(p) under the Securities Act, a registration fee credit of $11,182.75 is available to offset the current registration fee. |